← Evidence map

TrialInvestigational new drugs2001

Phase I study of irofulven (MGI 114), an acylfulvene illudin analog, in patients with acute leukemia.

F Giles et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2001

…

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

this papercites it

Phase I study of irofulven (MGI 114), an acylfulvene illudin analog, in patients with acute leukemia. | OpenQuestion